224 related articles for article (PubMed ID: 29177795)
1. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
[TBL] [Abstract][Full Text] [Related]
2. Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia.
Shiraki T; Iida O; Takahara M; Soga Y; Mii S; Okazaki J; Kuma S; Yamaoka T; Kamoi D; Shintani Y; Ishikawa T; Kitano I; Uematsu M
J Endovasc Ther; 2015 Oct; 22(5):719-24. PubMed ID: 26276552
[TBL] [Abstract][Full Text] [Related]
3. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization.
Shannon AH; Mehaffey JH; Cullen JM; Hawkins RB; Roy R; Upchurch GR; Robinson WP
J Vasc Surg; 2019 Apr; 69(4):1167-1172.e1. PubMed ID: 30598355
[TBL] [Abstract][Full Text] [Related]
4. Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis.
Velescu A; Clará A; Cladellas M; Peñafiel J; Mateos E; Ibañez S; Mellado M
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):543-9. PubMed ID: 26810343
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Endovascular 30-Day Outcomes for Critical Limb Threatening Ischemia Relative to Surgical Bypass Grafting.
Latz CA; Boitano L; Wang LJ; Pendleton AA; DeCarlo C; Sumpio B; Schwartz S; Srivastava S; Dua A
Vasc Endovascular Surg; 2021 Jul; 55(5):441-447. PubMed ID: 33602047
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia).
Iida O; Takahara M; Soga Y; Azuma N; Nanto S; Uematsu M;
JACC Cardiovasc Interv; 2017 Jun; 10(11):1147-1157. PubMed ID: 28595883
[TBL] [Abstract][Full Text] [Related]
7. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
8. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
[TBL] [Abstract][Full Text] [Related]
9. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
[TBL] [Abstract][Full Text] [Related]
11. Association between stress hormones and perioperative risk in patients with critical limb ischemia undergoing revascularization.
Soga Y; Takahara M; Iida O; Kodama A; Azuma N;
J Vasc Surg; 2019 Sep; 70(3):795-805.e1. PubMed ID: 30857850
[TBL] [Abstract][Full Text] [Related]
12. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia.
Singh GD; Armstrong EJ; Waldo SW; Alvandi B; Brinza E; Hildebrand J; Amsterdam EA; Humphries MD; Laird JR
Vasc Med; 2017 Jun; 22(3):210-217. PubMed ID: 28466753
[TBL] [Abstract][Full Text] [Related]
13. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
[TBL] [Abstract][Full Text] [Related]
14. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery.
; Devereaux PJ; Biccard BM; Sigamani A; Xavier D; Chan MTV; Srinathan SK; Walsh M; Abraham V; Pearse R; Wang CY; Sessler DI; Kurz A; Szczeklik W; Berwanger O; Villar JC; Malaga G; Garg AX; Chow CK; Ackland G; Patel A; Borges FK; Belley-Cote EP; Duceppe E; Spence J; Tandon V; Williams C; Sapsford RJ; Polanczyk CA; Tiboni M; Alonso-Coello P; Faruqui A; Heels-Ansdell D; Lamy A; Whitlock R; LeManach Y; Roshanov PS; McGillion M; Kavsak P; McQueen MJ; Thabane L; Rodseth RN; Buse GAL; Bhandari M; Garutti I; Jacka MJ; Schünemann HJ; Cortes OL; Coriat P; Dvirnik N; Botto F; Pettit S; Jaffe AS; Guyatt GH
JAMA; 2017 Apr; 317(16):1642-1651. PubMed ID: 28444280
[TBL] [Abstract][Full Text] [Related]
15. Endovascular Versus Surgical Revascularization for Acute Limb Ischemia: A Propensity-Score Matched Analysis.
Kolte D; Kennedy KF; Shishehbor MH; Mamdani ST; Stangenberg L; Hyder ON; Soukas P; Aronow HD
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008150. PubMed ID: 31948292
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Endovascular Outcomes for Critical Limb Ischemia Are Still Failing to Meet Society for Vascular Surgery Objective Performance Goals.
Latz CA; Wang LJ; Boitano L; DeCarlo C; Sumpio B; Schwartz S; Lee CJ; Dua A
Vasc Endovascular Surg; 2021 Jan; 55(1):33-38. PubMed ID: 33030116
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes.
Reed GW; Young L; Bagh I; Maier M; Shishehbor MH
JACC Cardiovasc Interv; 2017 Dec; 10(23):2451-2457. PubMed ID: 29153498
[TBL] [Abstract][Full Text] [Related]
18. Incident cardiovascular events and early mortality in patients with revascularized critical limb ischemia.
Gaisset R; Lin F; Borry O; Quemeneur C; Lazareth I; Emmerich J; Priollet P; Yannoutsos A
J Med Vasc; 2022 Feb; 47(1):19-26. PubMed ID: 35393087
[TBL] [Abstract][Full Text] [Related]
19. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
[TBL] [Abstract][Full Text] [Related]
20. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
Desai K; Han B; Kuziez L; Yan Y; Zayed MA
J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
